nodes	percent_of_prediction	percent_of_DWPC	metapath
Cycloserine—SLC36A2—renal system—kidney cancer	0.123	0.259	CbGeAlD
Cycloserine—SLC36A2—kidney—kidney cancer	0.119	0.25	CbGeAlD
Cycloserine—SLC36A2—gonad—kidney cancer	0.111	0.232	CbGeAlD
Cycloserine—DDC—nephron tubule—kidney cancer	0.0339	0.0711	CbGeAlD
Cycloserine—DDC—renal system—kidney cancer	0.0309	0.0647	CbGeAlD
Cycloserine—DDC—kidney—kidney cancer	0.0298	0.0625	CbGeAlD
Cycloserine—DDC—cortex of kidney—kidney cancer	0.0291	0.0609	CbGeAlD
Cycloserine—SLC36A2—Amino acid and oligopeptide SLC transporters—SLC5A5—kidney cancer	0.0188	0.0789	CbGpPWpGaD
Cycloserine—DDC—Biogenic Amine Synthesis—ACHE—kidney cancer	0.018	0.0755	CbGpPWpGaD
Cycloserine—DDC—Dopaminergic Neurogenesis—ALDH1A1—kidney cancer	0.0176	0.0738	CbGpPWpGaD
Cycloserine—Paresis—Vincristine—kidney cancer	0.0165	0.0579	CcSEcCtD
Cycloserine—Neurological symptom—Paclitaxel—kidney cancer	0.0158	0.0556	CcSEcCtD
Cycloserine—DDC—Parkinsons Disease Pathway—LRRK2—kidney cancer	0.0153	0.064	CbGpPWpGaD
Cycloserine—DDC—Amine-derived hormones—SLC5A5—kidney cancer	0.0147	0.0617	CbGpPWpGaD
Cycloserine—DDC—Tryptophan metabolism—ALDH1A1—kidney cancer	0.0125	0.0524	CbGpPWpGaD
Cycloserine—Drug hypersensitivity—Paclitaxel—kidney cancer	0.0119	0.0417	CcSEcCtD
Cycloserine—SLC36A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—kidney cancer	0.0111	0.0465	CbGpPWpGaD
Cycloserine—DDC—Parkinsons Disease Pathway—CASP2—kidney cancer	0.011	0.0463	CbGpPWpGaD
Cycloserine—DDC—Parkinsons Disease Pathway—APAF1—kidney cancer	0.0104	0.0435	CbGpPWpGaD
Cycloserine—Drug hypersensitivity—Capecitabine—kidney cancer	0.00973	0.0342	CcSEcCtD
Cycloserine—Aggression—Everolimus—kidney cancer	0.00968	0.034	CcSEcCtD
Cycloserine—SLC36A2—SLC-mediated transmembrane transport—SLC5A3—kidney cancer	0.00939	0.0394	CbGpPWpGaD
Cycloserine—Cardiac failure congestive—Pazopanib—kidney cancer	0.00862	0.0303	CcSEcCtD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—RYR1—kidney cancer	0.0083	0.0348	CbGpPWpGaD
Cycloserine—Cardiac failure congestive—Everolimus—kidney cancer	0.00681	0.0239	CcSEcCtD
Cycloserine—Drug hypersensitivity—Doxorubicin—kidney cancer	0.00627	0.022	CcSEcCtD
Cycloserine—DDC—Amino acid and derivative metabolism—CCBL1—kidney cancer	0.00591	0.0248	CbGpPWpGaD
Cycloserine—Cardiac failure congestive—Sorafenib—kidney cancer	0.00591	0.0208	CcSEcCtD
Cycloserine—Cardiac failure congestive—Sunitinib—kidney cancer	0.00569	0.02	CcSEcCtD
Cycloserine—Coma—Vincristine—kidney cancer	0.00549	0.0193	CcSEcCtD
Cycloserine—SLC36A2—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	0.00495	0.0208	CbGpPWpGaD
Cycloserine—SLC36A2—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	0.00478	0.0201	CbGpPWpGaD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—ANXA2—kidney cancer	0.00477	0.02	CbGpPWpGaD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—ATP7B—kidney cancer	0.00477	0.02	CbGpPWpGaD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—SLC5A3—kidney cancer	0.00477	0.02	CbGpPWpGaD
Cycloserine—Cardiac failure congestive—Gemcitabine—kidney cancer	0.00456	0.016	CcSEcCtD
Cycloserine—DDC—Tryptophan metabolism—CYP1A1—kidney cancer	0.00444	0.0186	CbGpPWpGaD
Cycloserine—Convulsion—Temsirolimus—kidney cancer	0.00433	0.0152	CcSEcCtD
Cycloserine—Dysarthria—Capecitabine—kidney cancer	0.00414	0.0146	CcSEcCtD
Cycloserine—Cardiac failure congestive—Paclitaxel—kidney cancer	0.00382	0.0134	CcSEcCtD
Cycloserine—Somnolence—Temsirolimus—kidney cancer	0.00363	0.0128	CcSEcCtD
Cycloserine—Tremor—Everolimus—kidney cancer	0.00348	0.0122	CcSEcCtD
Cycloserine—Paraesthesia—Pazopanib—kidney cancer	0.00345	0.0121	CcSEcCtD
Cycloserine—Somnolence—Pazopanib—kidney cancer	0.00342	0.012	CcSEcCtD
Cycloserine—Vertigo—Vinblastine—kidney cancer	0.00335	0.0118	CcSEcCtD
Cycloserine—DDC—SIDS Susceptibility Pathways—HSPD1—kidney cancer	0.00335	0.0141	CbGpPWpGaD
Cycloserine—Convulsion—Vinblastine—kidney cancer	0.00323	0.0114	CcSEcCtD
Cycloserine—Convulsion—Everolimus—kidney cancer	0.00322	0.0113	CcSEcCtD
Cycloserine—DDC—Circadian rythm related genes—HNF1B—kidney cancer	0.00313	0.0131	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—KCNMA1—kidney cancer	0.00305	0.0128	CbGpPWpGaD
Cycloserine—Hypersensitivity—Temsirolimus—kidney cancer	0.00301	0.0106	CcSEcCtD
Cycloserine—Osteoarthritis—Capecitabine—kidney cancer	0.00284	0.01	CcSEcCtD
Cycloserine—DDC—SIDS Susceptibility Pathways—IL13—kidney cancer	0.00282	0.0118	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—JUND—kidney cancer	0.00274	0.0115	CbGpPWpGaD
Cycloserine—Paraesthesia—Vinblastine—kidney cancer	0.00274	0.00962	CcSEcCtD
Cycloserine—Paraesthesia—Everolimus—kidney cancer	0.00273	0.00958	CcSEcCtD
Cycloserine—Somnolence—Everolimus—kidney cancer	0.0027	0.00949	CcSEcCtD
Cycloserine—Convulsion—Sunitinib—kidney cancer	0.00269	0.00946	CcSEcCtD
Cycloserine—Dysarthria—Doxorubicin—kidney cancer	0.00267	0.00939	CcSEcCtD
Cycloserine—Rash—Temsirolimus—kidney cancer	0.00257	0.00905	CcSEcCtD
Cycloserine—Dermatitis—Temsirolimus—kidney cancer	0.00257	0.00904	CcSEcCtD
Cycloserine—Headache—Temsirolimus—kidney cancer	0.00256	0.00899	CcSEcCtD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.00252	0.0105	CbGpPWpGaD
Cycloserine—Feeling abnormal—Vinblastine—kidney cancer	0.00251	0.00883	CcSEcCtD
Cycloserine—Feeling abnormal—Everolimus—kidney cancer	0.0025	0.00879	CcSEcCtD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.00243	0.0102	CbGpPWpGaD
Cycloserine—Rash—Pazopanib—kidney cancer	0.00242	0.00852	CcSEcCtD
Cycloserine—Dermatitis—Pazopanib—kidney cancer	0.00242	0.00851	CcSEcCtD
Cycloserine—Headache—Pazopanib—kidney cancer	0.00241	0.00847	CcSEcCtD
Cycloserine—Vertigo—Vincristine—kidney cancer	0.00236	0.0083	CcSEcCtD
Cycloserine—Coma—Doxorubicin—kidney cancer	0.00231	0.00811	CcSEcCtD
Cycloserine—Paraesthesia—Sunitinib—kidney cancer	0.00228	0.008	CcSEcCtD
Cycloserine—Convulsion—Vincristine—kidney cancer	0.00228	0.008	CcSEcCtD
Cycloserine—Hypersensitivity—Vinblastine—kidney cancer	0.00224	0.00789	CcSEcCtD
Cycloserine—Hypersensitivity—Everolimus—kidney cancer	0.00224	0.00786	CcSEcCtD
Cycloserine—DDC—Amino acid and derivative metabolism—PSMD7—kidney cancer	0.00219	0.00918	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—EGR1—kidney cancer	0.00213	0.00895	CbGpPWpGaD
Cycloserine—DDC—Amino acid and derivative metabolism—SLC5A5—kidney cancer	0.00205	0.0086	CbGpPWpGaD
Cycloserine—Cardiac failure congestive—Doxorubicin—kidney cancer	0.00202	0.00711	CcSEcCtD
Cycloserine—Feeling abnormal—Dactinomycin—kidney cancer	0.00198	0.00695	CcSEcCtD
Cycloserine—Tremor—Paclitaxel—kidney cancer	0.00196	0.00687	CcSEcCtD
Cycloserine—Hypersensitivity—Sorafenib—kidney cancer	0.00194	0.00682	CcSEcCtD
Cycloserine—Paraesthesia—Vincristine—kidney cancer	0.00193	0.00677	CcSEcCtD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.00192	0.00804	CbGpPWpGaD
Cycloserine—Rash—Everolimus—kidney cancer	0.00191	0.00673	CcSEcCtD
Cycloserine—Dermatitis—Everolimus—kidney cancer	0.00191	0.00672	CcSEcCtD
Cycloserine—Headache—Vinblastine—kidney cancer	0.00191	0.00671	CcSEcCtD
Cycloserine—Headache—Everolimus—kidney cancer	0.0019	0.00668	CcSEcCtD
Cycloserine—Vertigo—Paclitaxel—kidney cancer	0.00187	0.00659	CcSEcCtD
Cycloserine—Hypersensitivity—Sunitinib—kidney cancer	0.00187	0.00657	CcSEcCtD
Cycloserine—Rash—Erlotinib—kidney cancer	0.00185	0.00649	CcSEcCtD
Cycloserine—Dermatitis—Erlotinib—kidney cancer	0.00184	0.00649	CcSEcCtD
Cycloserine—Headache—Erlotinib—kidney cancer	0.00183	0.00645	CcSEcCtD
Cycloserine—Osteoarthritis—Doxorubicin—kidney cancer	0.00183	0.00644	CcSEcCtD
Cycloserine—Paraesthesia—Gemcitabine—kidney cancer	0.00183	0.00642	CcSEcCtD
Cycloserine—Somnolence—Gemcitabine—kidney cancer	0.00181	0.00636	CcSEcCtD
Cycloserine—Convulsion—Paclitaxel—kidney cancer	0.00181	0.00636	CcSEcCtD
Cycloserine—Hypersensitivity—Dactinomycin—kidney cancer	0.00177	0.00622	CcSEcCtD
Cycloserine—DDC—Circadian rythm related genes—EGR1—kidney cancer	0.00174	0.00731	CbGpPWpGaD
Cycloserine—Confusional state—Paclitaxel—kidney cancer	0.00172	0.00604	CcSEcCtD
Cycloserine—Feeling abnormal—Gemcitabine—kidney cancer	0.00168	0.00589	CcSEcCtD
Cycloserine—Rash—Sorafenib—kidney cancer	0.00166	0.00584	CcSEcCtD
Cycloserine—Dermatitis—Sorafenib—kidney cancer	0.00166	0.00583	CcSEcCtD
Cycloserine—Headache—Sorafenib—kidney cancer	0.00165	0.0058	CcSEcCtD
Cycloserine—Tremor—Capecitabine—kidney cancer	0.0016	0.00564	CcSEcCtD
Cycloserine—Rash—Sunitinib—kidney cancer	0.0016	0.00562	CcSEcCtD
Cycloserine—Dermatitis—Sunitinib—kidney cancer	0.0016	0.00561	CcSEcCtD
Cycloserine—Headache—Sunitinib—kidney cancer	0.00159	0.00558	CcSEcCtD
Cycloserine—Hypersensitivity—Vincristine—kidney cancer	0.00158	0.00555	CcSEcCtD
Cycloserine—Vertigo—Capecitabine—kidney cancer	0.00154	0.00541	CcSEcCtD
Cycloserine—Paraesthesia—Paclitaxel—kidney cancer	0.00153	0.00538	CcSEcCtD
Cycloserine—Somnolence—Paclitaxel—kidney cancer	0.00151	0.00532	CcSEcCtD
Cycloserine—Rash—Dactinomycin—kidney cancer	0.00151	0.00532	CcSEcCtD
Cycloserine—DDC—SIDS Susceptibility Pathways—HIF1A—kidney cancer	0.00148	0.00623	CbGpPWpGaD
Cycloserine—Drowsiness—Doxorubicin—kidney cancer	0.00141	0.00497	CcSEcCtD
Cycloserine—Confusional state—Capecitabine—kidney cancer	0.00141	0.00495	CcSEcCtD
Cycloserine—Feeling abnormal—Paclitaxel—kidney cancer	0.0014	0.00493	CcSEcCtD
Cycloserine—DDC—Metabolism—ACY1—kidney cancer	0.00136	0.0057	CbGpPWpGaD
Cycloserine—Rash—Vincristine—kidney cancer	0.00135	0.00475	CcSEcCtD
Cycloserine—Dermatitis—Vincristine—kidney cancer	0.00135	0.00475	CcSEcCtD
Cycloserine—Headache—Vincristine—kidney cancer	0.00134	0.00472	CcSEcCtD
Cycloserine—Rash—Gemcitabine—kidney cancer	0.00128	0.00451	CcSEcCtD
Cycloserine—Dermatitis—Gemcitabine—kidney cancer	0.00128	0.00451	CcSEcCtD
Cycloserine—Headache—Gemcitabine—kidney cancer	0.00127	0.00448	CcSEcCtD
Cycloserine—Paraesthesia—Capecitabine—kidney cancer	0.00125	0.00441	CcSEcCtD
Cycloserine—Hypersensitivity—Paclitaxel—kidney cancer	0.00125	0.00441	CcSEcCtD
Cycloserine—DDC—Metabolism—PDHB—kidney cancer	0.00116	0.00484	CbGpPWpGaD
Cycloserine—Feeling abnormal—Capecitabine—kidney cancer	0.00115	0.00405	CcSEcCtD
Cycloserine—DDC—Metabolism—CCBL1—kidney cancer	0.00109	0.00456	CbGpPWpGaD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—RAF1—kidney cancer	0.00109	0.00455	CbGpPWpGaD
Cycloserine—Rash—Paclitaxel—kidney cancer	0.00107	0.00378	CcSEcCtD
Cycloserine—Dermatitis—Paclitaxel—kidney cancer	0.00107	0.00377	CcSEcCtD
Cycloserine—Headache—Paclitaxel—kidney cancer	0.00107	0.00375	CcSEcCtD
Cycloserine—Hypersensitivity—Capecitabine—kidney cancer	0.00103	0.00362	CcSEcCtD
Cycloserine—Vertigo—Doxorubicin—kidney cancer	0.000992	0.00349	CcSEcCtD
Cycloserine—Convulsion—Doxorubicin—kidney cancer	0.000956	0.00336	CcSEcCtD
Cycloserine—DDC—Metabolism—GLIPR1—kidney cancer	0.000942	0.00395	CbGpPWpGaD
Cycloserine—DDC—Metabolism—PPAT—kidney cancer	0.000942	0.00395	CbGpPWpGaD
Cycloserine—Confusional state—Doxorubicin—kidney cancer	0.000908	0.00319	CcSEcCtD
Cycloserine—DDC—SIDS Susceptibility Pathways—JUN—kidney cancer	0.000895	0.00376	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—CTNNB1—kidney cancer	0.000889	0.00373	CbGpPWpGaD
Cycloserine—Rash—Capecitabine—kidney cancer	0.000881	0.0031	CcSEcCtD
Cycloserine—Dermatitis—Capecitabine—kidney cancer	0.00088	0.0031	CcSEcCtD
Cycloserine—Headache—Capecitabine—kidney cancer	0.000876	0.00308	CcSEcCtD
Cycloserine—DDC—Metabolism—APRT—kidney cancer	0.000875	0.00367	CbGpPWpGaD
Cycloserine—DDC—Metabolism—FH—kidney cancer	0.000875	0.00367	CbGpPWpGaD
Cycloserine—DDC—Metabolism—GPC3—kidney cancer	0.000823	0.00345	CbGpPWpGaD
Cycloserine—Paraesthesia—Doxorubicin—kidney cancer	0.000809	0.00284	CcSEcCtD
Cycloserine—Somnolence—Doxorubicin—kidney cancer	0.000801	0.00282	CcSEcCtD
Cycloserine—DDC—Metabolism—CA2—kidney cancer	0.000801	0.00336	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—VEGFA—kidney cancer	0.000782	0.00328	CbGpPWpGaD
Cycloserine—DDC—Metabolism—ALAD—kidney cancer	0.00078	0.00327	CbGpPWpGaD
Cycloserine—DDC—Metabolism—ST3GAL2—kidney cancer	0.000762	0.00319	CbGpPWpGaD
Cycloserine—DDC—Metabolism—ALDH1A1—kidney cancer	0.000744	0.00312	CbGpPWpGaD
Cycloserine—Feeling abnormal—Doxorubicin—kidney cancer	0.000742	0.00261	CcSEcCtD
Cycloserine—DDC—Circadian rythm related genes—JUN—kidney cancer	0.000731	0.00307	CbGpPWpGaD
Cycloserine—DDC—Metabolism—SLC5A3—kidney cancer	0.000714	0.00299	CbGpPWpGaD
Cycloserine—DDC—Metabolism—PGK1—kidney cancer	0.000714	0.00299	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—PTEN—kidney cancer	0.000707	0.00297	CbGpPWpGaD
Cycloserine—DDC—Metabolism—LDHB—kidney cancer	0.0007	0.00294	CbGpPWpGaD
Cycloserine—Hypersensitivity—Doxorubicin—kidney cancer	0.000664	0.00233	CcSEcCtD
Cycloserine—DDC—Metabolism—CA9—kidney cancer	0.000607	0.00254	CbGpPWpGaD
Cycloserine—Rash—Doxorubicin—kidney cancer	0.000568	0.002	CcSEcCtD
Cycloserine—Dermatitis—Doxorubicin—kidney cancer	0.000568	0.002	CcSEcCtD
Cycloserine—Headache—Doxorubicin—kidney cancer	0.000564	0.00198	CcSEcCtD
Cycloserine—DDC—Metabolism—CRABP1—kidney cancer	0.000516	0.00216	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—TP53—kidney cancer	0.000483	0.00202	CbGpPWpGaD
Cycloserine—DDC—Metabolism—ITPR2—kidney cancer	0.00048	0.00201	CbGpPWpGaD
Cycloserine—DDC—Metabolism—ACHE—kidney cancer	0.000437	0.00183	CbGpPWpGaD
Cycloserine—DDC—Metabolism—GSTT1—kidney cancer	0.000437	0.00183	CbGpPWpGaD
Cycloserine—DDC—Metabolism—SCARB1—kidney cancer	0.000414	0.00174	CbGpPWpGaD
Cycloserine—DDC—Metabolism—PTGS1—kidney cancer	0.00041	0.00172	CbGpPWpGaD
Cycloserine—DDC—Metabolism—PSMD7—kidney cancer	0.000402	0.00169	CbGpPWpGaD
Cycloserine—DDC—Metabolism—BCHE—kidney cancer	0.000381	0.0016	CbGpPWpGaD
Cycloserine—DDC—Metabolism—SLC5A5—kidney cancer	0.000376	0.00158	CbGpPWpGaD
Cycloserine—DDC—Metabolism—SLC2A1—kidney cancer	0.000364	0.00152	CbGpPWpGaD
Cycloserine—DDC—Metabolism—GSTP1—kidney cancer	0.000303	0.00127	CbGpPWpGaD
Cycloserine—DDC—Metabolism—ABCB1—kidney cancer	0.000287	0.0012	CbGpPWpGaD
Cycloserine—DDC—Metabolism—GSTM1—kidney cancer	0.000279	0.00117	CbGpPWpGaD
Cycloserine—DDC—Metabolism—CYP1A1—kidney cancer	0.000264	0.00111	CbGpPWpGaD
Cycloserine—DDC—Metabolism—POMC—kidney cancer	0.000197	0.000826	CbGpPWpGaD
Cycloserine—DDC—Metabolism—PTGS2—kidney cancer	0.000157	0.000659	CbGpPWpGaD
Cycloserine—DDC—Metabolism—PTEN—kidney cancer	0.000137	0.000575	CbGpPWpGaD
Cycloserine—DDC—Metabolism—PIK3CA—kidney cancer	9.66e-05	0.000405	CbGpPWpGaD
